Biliary and urinary excretion of inorganic arsenic: Monomethylarsonous acid as a major biliary metabolite in rats

被引:98
作者
Gregus, Z [1 ]
Gyurasics, A [1 ]
Csanaky, I [1 ]
机构
[1] Univ Pecs, Sch Med, Dept Pharmacol, H-7643 Pecs, Hungary
关键词
arsenic; monomethylarsonous acid; biliary excretion; methylation; urinary excretion;
D O I
10.1093/toxsci/56.1.18
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
In rats exposed to arsenite (As-III) or arsenate (AsV), the biliary excretion of arsenic depends completely on availability of hepatic glutathione, suggesting that both As-III and AsV are transported into bile in thiol-reactive trivalent form (Gyurasics et al. [1991], Biochem. Pharmacol. 42, 465-368). To test this hypothesis, the bile and urine of bile duct-cannulated rats injected with AsIII or AsV (50 mu mol/kg. iv) were collected periodically for 2 h and analyzed for arsenic metabolites by HPLC-hydride generation-atomic fluorescence spectrometry. Arsenic was excreted predominantly into bile in AsIII-injected rats, but the urine was the main route of excretion in AsV-exposed rats. Injected Asm was excreted in urine practically unchanged, whereas both AsV and AsIII appeared in urine after administration of AsV. Irrespective of the arsenical administered, the bile contained 2 main arsenic species, namely AsIII and a hitherto unidentified metabolite. Formation of this metabolite could be prevented by pretreatment of the rats with the methylation inhibitor periodate-oxidized adenosine, indicating that it is a methylated arsenic compound. This metabolite could be converted in vitro into monomethylarsonic acid (MMAsV) by oxidation, whereas synthetic MAAsV could be converted into the unknown metabolite by reduction. Consequently, this biliary metabolite of both AsIII and AsV is monomethylarsonous acid (MMAsIII), a long-hypothesized, but never identified, intermediate in the biotransformation of AsIII and AsV. Although MMAsIII is thought to be formed from an oxidized precursor, rats injected with MMAsV did not excrete MMAsIII. in summary, the inoreanic arsenicals investigated are transported into bile exclusively in trivalent forms, namely as AsIII and MMAsIII, but are excreted in urine in both tri- and pentavalent forms. Identification of MMAsIII is signified by the fact that this metabolite is more toxic than AsIII and AsV and thus formation of MMAsIII represents toxification of inorganic arsenic.
引用
收藏
页码:18 / 25
页数:8
相关论文
共 50 条
  • [41] Biliary excretion of pravastatin and taurocholate in rats with bile salt export pump (Bsep) impairment
    Cheng, Yaofeng
    Freeden, Chris
    Zhang, Yueping
    Abraham, Pamela
    Shen, Hong
    Wescott, Debra
    Humphreys, W. Griffith
    Gan, Jinping
    Lai, Yurong
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2016, 37 (05) : 276 - 286
  • [42] PLASMA PHARMACOKINETICS AND URINARY AND BILIARY-EXCRETION OF A NEW POTENT TRIPEPTIDE HIV-1 PROTEASE INHIBITOR, KNI-272, IN RATS AFTER INTRAVENOUS ADMINISTRATION
    KIRIYAMA, A
    FUJITA, K
    TAKEMURA, S
    KURAMOTO, H
    KISO, Y
    TAKADA, K
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1994, 15 (07) : 617 - 626
  • [43] Day-to-day variation in urinary excretion of the histamine metabolite methylimidazoleacetic acid
    G. Granerus
    B. Lönnqvist
    M. Källberg
    B. Kågedal
    Inflammation Research, 1998, 47 (Suppl 1) : 52 - 53
  • [44] No sex difference in the urinary excretion of the histamine metabolite methylimidazoleacetic acid (MeImAA) when corrected for creatinine excretion
    G. Granerus
    B. Lönnqvist
    M. Stenström <!-RID="h1"--> <!-ID="h1" Correspondence to: G. Granerus-->
    Inflammation Research, 1999, 48 (Suppl 1) : 92 - 93
  • [45] Glucuronidation and Subsequent Biliary Excretion of Mycophenolic Acid in Rat Sandwich-cultured Hepatocytes
    Tetsuka, Kazuhiro
    Gerst, Nicolas
    Tamura, Kouichi
    Masters, Jeffrey N.
    DRUG METABOLISM AND PHARMACOKINETICS, 2014, 29 (02) : 129 - 134
  • [46] STUDIES IN THE RAT ON THE HEPATIC SUBCELLULAR-DISTRIBUTION AND BILIARY-EXCRETION OF LITHOCHOLIC ACID
    STRANGE, RC
    NIMMO, IA
    PERCYROBB, IW
    BIOCHIMICA ET BIOPHYSICA ACTA, 1979, 588 (01) : 70 - 80
  • [47] Comparative pharmacokinetics and urinary excretion of arsenic and mercury after oral administration of realgar, cinnabar and AnGongNiuHuang Pill to rats
    Wu, Xiao
    Zhong, Zeling
    Lin, Kuangmin
    Liu, Xinhe
    Wu, Zhichao
    Liu, Zitian
    Li, Yongming
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [48] Biliary excretion of glycyrrhizin in rats: Kinetic basis for multiplicity in bile canalicular transport of organic anions
    Shimamura, H
    Suzuki, H
    Tagaya, O
    Horie, T
    Sugiyama, Y
    PHARMACEUTICAL RESEARCH, 1996, 13 (12) : 1833 - 1837
  • [49] PHARMACOKINETIC PARAMETERS FROM DATA RELATING TO THE PLASMA AND BILIARY-EXCRETION KINETICS OF CEFMETAZOLE IN RATS
    GARCIAAGUNDEZ, MJ
    FERNANDEZLASTRA, C
    JIMENEZ, R
    GONZALEZ, J
    MARINO, EL
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1992, 17 (03) : 167 - 173
  • [50] Biliary excretion of essential trace elements in rats under oxidative stress caused by selenium deficiency
    Kosuke Yamasaki
    Yasunobu Sakuma
    Junya Sasaki
    Ken-ichiro Matsumoto
    Kazunori Anzai
    Keisuke Matsuoka
    Chikako Honda
    Masamichi Tsukada
    Kazutoyo Endo
    Shuichi Enomoto
    Analytical and Bioanalytical Chemistry, 2011, 401 : 2531 - 2538